FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244823657> ?p ?o ?g. }

• W4244823657 abstract "Abstract Background Cyanoacrylate alone or in combination with other interventions, can be used to achieve variable rates of successes in preventing rebleeding. Our study aims to assess the pooled risk of gastric and esophageal varices rebleeding after an initial treatment with cyanoacrylate alone and/or in combination with other treatments, by systematic review of literature and pooled analysis.Methodology PubMed, EMBASE, SCOPUS and the Cochrane library were searched for studies that reported the risk of rebleeding during the follow-up period after treatment of gastric or esophageal varices with either cyanoacrylate alone or in combination with other treatments. Standard error, upper and lower confidence intervals at 95% confidence interval for the risk, were obtained STATA Version 15 which was also used to generate forest plots for pooled analysis. Random or fixed effect model was used depending on the heterogeneity (I2).Results A total of 39 studies were found to report treatment of either gastric or esophageal varices with either cyanoacrylate alone or in combination with other treatments. When gastric varices are treated with cyanoacrylate alone, the risk of rebleeding during the follow-up period is 0.16(Confidence Interval: 0.13-0.18). When combined with lipiodol; polidocanol or sclerotherapy the rebleeding risks are 0.13 (CI:0.03-0.22), 0.10(CI:0.02-0.19) and 0.10(CI:0.05-0.18), respectively. When combined with percutaneous transhepatic variceal embolization; percutaneous transhepatic variceal embolization; endoscopic ultrasound guided coils; or with ethanolamine, the rebleeding risk are 0.10(CI:0.03-0.17), 0.10(CI:0.03-0.17), 0.07(CI:0.03-0.11) and 0.08(CI:0.02-0.14), respectively. When esophageal varices are treated with cyanoacrylate alone, the risk of rebleeding is 0.29(CI:0.11-0.47). When combined with percutaneous transhepatic variceal embolization; sclerotherapy; or band ligation, the risks of rebleeding are 0.16(CI:0.10-0.22), 0.12(CI:0.04-0.20) and 0.10(CI:0.04-0.24), respectively. When combined with transjugular intrahepatic portosystemic shunt; or ethanolamine, the risks of rebleeding are 0.06(CI:-0.01-0.12) and 0.02 (CI:-0.02-0.05), respectively.Conclusion In treating both gastric and esophageal varices, cyanoacrylate produces better results in terms of lower risk of rebleeding when combined with other treatments than when used alone. The combination of cyanoacrylate with ethanolamine or with endoscopic ultrasound guided coils produces lowest risk of rebleeding in esophageal and gastric varices, respectively. We call upon randomized trials to test these hypotheses." @default.
• W4244823657 created "2022-05-12" @default.
• W4244823657 creator A5013297039 @default.
• W4244823657 creator A5045997628 @default.
• W4244823657 creator A5055865125 @default.
• W4244823657 creator A5063286654 @default.
• W4244823657 creator A5066791942 @default.
• W4244823657 date "2020-03-18" @default.
• W4244823657 modified "2023-10-17" @default.
• W4244823657 title "Risk of rebleeding from gastroesophageal varices after initial treatment with cyanoacrylate: a systematic review and pooled analysis." @default.
• W4244823657 doi "https://doi.org/10.21203/rs.3.rs-17635/v1" @default.
• W4244823657 hasPublicationYear "2020" @default.
• W4244823657 type Work @default.
• W4244823657 citedByCount "0" @default.
• W4244823657 crossrefType "posted-content" @default.
• W4244823657 hasAuthorship W4244823657A5013297039 @default.
• W4244823657 hasAuthorship W4244823657A5045997628 @default.
• W4244823657 hasAuthorship W4244823657A5055865125 @default.
• W4244823657 hasAuthorship W4244823657A5063286654 @default.
• W4244823657 hasAuthorship W4244823657A5066791942 @default.
• W4244823657 hasConcept C126322002 @default.
• W4244823657 hasConcept C141071460 @default.
• W4244823657 hasConcept C178790620 @default.
• W4244823657 hasConcept C185592680 @default.
• W4244823657 hasConcept C2776035437 @default.
• W4244823657 hasConcept C2776478404 @default.
• W4244823657 hasConcept C2777214474 @default.
• W4244823657 hasConcept C2777595160 @default.
• W4244823657 hasConcept C2777819096 @default.
• W4244823657 hasConcept C2778012290 @default.
• W4244823657 hasConcept C2778171257 @default.
• W4244823657 hasConcept C2778230777 @default.
• W4244823657 hasConcept C2778448856 @default.
• W4244823657 hasConcept C2778808290 @default.
• W4244823657 hasConcept C2779195621 @default.
• W4244823657 hasConcept C2779227376 @default.
• W4244823657 hasConcept C2780950165 @default.
• W4244823657 hasConcept C44249647 @default.
• W4244823657 hasConcept C68928338 @default.
• W4244823657 hasConcept C71924100 @default.
• W4244823657 hasConcept C82789193 @default.
• W4244823657 hasConcept C90924648 @default.
• W4244823657 hasConcept C95190672 @default.
• W4244823657 hasConceptScore W4244823657C126322002 @default.
• W4244823657 hasConceptScore W4244823657C141071460 @default.
• W4244823657 hasConceptScore W4244823657C178790620 @default.
• W4244823657 hasConceptScore W4244823657C185592680 @default.
• W4244823657 hasConceptScore W4244823657C2776035437 @default.
• W4244823657 hasConceptScore W4244823657C2776478404 @default.
• W4244823657 hasConceptScore W4244823657C2777214474 @default.
• W4244823657 hasConceptScore W4244823657C2777595160 @default.
• W4244823657 hasConceptScore W4244823657C2777819096 @default.
• W4244823657 hasConceptScore W4244823657C2778012290 @default.
• W4244823657 hasConceptScore W4244823657C2778171257 @default.
• W4244823657 hasConceptScore W4244823657C2778230777 @default.
• W4244823657 hasConceptScore W4244823657C2778448856 @default.
• W4244823657 hasConceptScore W4244823657C2778808290 @default.
• W4244823657 hasConceptScore W4244823657C2779195621 @default.
• W4244823657 hasConceptScore W4244823657C2779227376 @default.
• W4244823657 hasConceptScore W4244823657C2780950165 @default.
• W4244823657 hasConceptScore W4244823657C44249647 @default.
• W4244823657 hasConceptScore W4244823657C68928338 @default.
• W4244823657 hasConceptScore W4244823657C71924100 @default.
• W4244823657 hasConceptScore W4244823657C82789193 @default.
• W4244823657 hasConceptScore W4244823657C90924648 @default.
• W4244823657 hasConceptScore W4244823657C95190672 @default.
• W4244823657 hasLocation W42448236571 @default.
• W4244823657 hasOpenAccess W4244823657 @default.
• W4244823657 hasPrimaryLocation W42448236571 @default.
• W4244823657 hasRelatedWork W10574317 @default.
• W4244823657 hasRelatedWork W10631629 @default.
• W4244823657 hasRelatedWork W12435958 @default.
• W4244823657 hasRelatedWork W1295218 @default.
• W4244823657 hasRelatedWork W16369270 @default.
• W4244823657 hasRelatedWork W16376109 @default.
• W4244823657 hasRelatedWork W3309218 @default.
• W4244823657 hasRelatedWork W5615271 @default.
• W4244823657 hasRelatedWork W7310331 @default.
• W4244823657 hasRelatedWork W7746022 @default.
• W4244823657 isParatext "false" @default.
• W4244823657 isRetracted "false" @default.
• W4244823657 workType "article" @default.